. Toxicity assessment of EISO, α-and β-santalols on wild type C. elegans. Acute and chronic exposure to various pharmacological doses/molarities of EISO and its principal components did not significantly affect the survival of nematodes (n=20~25/replicate) compared to control at 20°C. Data are presented as mean±SEM of three independent runs, and analyzed by one way analysis of variance (ANOVA) followed by Bonferroni post-hoc test. Table 4 . Lifespan analysis of NL5901 C. elegans cultured at 20°C supplemented with various pharmacological doses of EISO, α-and β-santalol. The mean lifespan of NL5901 worms were calculated using Kaplan-Meir survival analysis and significance levels were estimated by longrank test in Medcalc statistical tool.
Page | 10 Table 6 . Influences of EISO, α-and β-santalol on CED-1::GFP expression in C. elegans. The 6-OHDA-induced elevation in clustering of CED-1::GFP around cell corpses was greatly attenuated with EISO, α-and β-santalol treatment in MD701 C. elegans. Data were pooled from biological triplicates in experimental duplicates and presented as mean±SEM. A hash (#) mark indicates significant differences (p<0.001) between 6-OHDA exposed and unexposed (control) worms, an asterisk (**) indicate significant difference between 6-OHDA exposed and 6-OHDA/EGCG, EISO, α-or β-santalol treated groups (p< 0.001). Table 7 . Genetic requirement for EISO, α-and β-santalol-mediated geroprotection against 6-OHDA-induced toxicity in C. elegans. The mean lifespan of C. elegans mutants were calculated using Kaplan-Meir survival analysis and significance levels were estimated by long-rank test in Medcalc statistical tool. For the analysis of statistical significance, 6-OHDA alone treated group was compared with untreated control, and 6-OHDA/EISO, α-or β-santalol treated groups were compared with 6-OHDA alone treated group. elegans. The survival graphs showed the effect of dietary supplemented (A) EISO (B1-2) α-santalol and (C1-2) β-santalol on the lifespan of transgenic C. elegans strain NL5901 constitutively express human α-synuclein (a Parkinson's related protein) in body wall muscles. The survival curves were plotted using Kaplan-Meier survival analysis and significance levels were estimated by long-rank test in Medcalc statistical software v.14. The representative KaplanMeier survival curves from three independent runs were presented. Histogram represents the changes in expression across various treatments. Data shown here are mean±SEM, the probability levels of p<0.05 were considered as statistically significant. *p<0.05, **p<0.01 and ns not significant.
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Figure 6
Fig. 6. Proposed interaction of (A) α-santalol and (B) β-santalol on the binding cleft of Klech domain of Keap1. The representative three-dimensional and two-dimensional interaction map shows the binding mode of α-and β-santalol (stick style in a green color) through hydrogen bonds (yellow dashed lines) with Keap1 (shown in ribbon style and colored shape). The pink arrow in two-dimensional image indicates potential interactions between amino acid residues and α-or β-santalol.
